Henlius to Initiate P-III Study of HLX04-O (biosimilar, bevacizumab) in Australia

Henlius to Initiate P-III Study of HLX04-O (biosimilar, bevacizumab) in Australia

Henlius to Initiate P-III Study of HLX04-O (biosimilar, bevacizumab) in Australia

Parag Narang

Parag Narang is a Digital Marketing Associate at PharmaShots, a division of Octavus Consulting. He manages the digital marketing as well as the designing ideas for PharmaShots. He has a degree in Bachelor of Business Administration along with Post Graduate Program in Management (Marketing). Parag manages all the social media handles very well since he has a good experience in Marketing & Sales.

Related post